Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study

By Nierenberg Andrew A.   Greist John H.   Mallinckrodt Craig H.   Prakash Apurva   Sambunaris Angelo   Tollefson Gary D.   Wohlreich Madelaine M.  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 401-416

Informa Healthcare

Access to resources Recommend Favorite

The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder

By Fishbain David A.   Detke Michael J.   Wernicke Joachim   Chappell Amy S.   Kajdasz Daniel K.  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3105-3115

Informa Healthcare

Access to resources Recommend Favorite

Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapy

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 68, Iss. 11, 2014-11 ,pp. : 1301-1308

John Wiley & Sons Inc

Access to resources Recommend Favorite

Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder

By Pigott Teresa A.   Prakash Apurva   Arnold Lesley M.   Aaronson Scott T.   Mallinckrodt Craig H.   Wohlreich Madelaine M.  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1303-1318

Informa Healthcare

Access to resources Recommend Favorite

A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms

By Gaynor Paula J.   Gopal Murali   Zheng Wei   Martinez James M.   Robinson Michael J.   Marangell Lauren B.  

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 1849-1858

Informa Healthcare

Access to resources Recommend Favorite